Clinical Study
Cardioembolic but Not Other Stroke Subtypes Predict Mortality Independent of Stroke Severity at Presentation
Table 2
Survival estimates within the first year.
| | TOAST | | Events | Survival at 90 days (SE) | Survival at 180 days (SE) | Survival at 360 days (SE) |
| | Large artery | 97 | 16 | 87.1% (0.04) | 82.4% (0.04) | 82.4% (0.04) | | Cardioembolic | 144 | 57 | 67.1% (0.04) | 65.5% (0.04) | 58.2% (0.04) | | Small vessels | 75 | 4 | 98.6% (0.01) | 97.1% (0.02) | 94.2% (0.03) | | Other | 19 | 3 | 89.5% (0.07) | 84.2% (0.08) | 84.2% (0.08) | | Cryptogenic | 165 | 45 | 78.0% (0.03) | 75.3% (0.03) | 71.1% (0.04) | | More than one cause | 37 | 7 | 85.5% (0.06) | 82.3% (0.07) | 79.2% (0.07) | | No cause | 63 | 7 | 94.8% (0.03) | 91.2% (0.04) | 87.4% (0.05) | | Insufficient info | 65 | 31 | 57.7% (0.06) | 56.1% (0.06) | 51.2% (0.06) |
|
|
